Study of Potential for Drug Interactions Mediated by CYP3A4 Inhibition With Aramchol in Healthy Volunteers
Clinical trial NCT03760848 · COMPLETED
Trial details
- NCT number
- NCT03760848
- Sponsor
- Galmed Pharmaceuticals Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-12
- Primary completion
- 2019-02-02
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.